SOX2 and central nervous system cancer: These data indicate that DNA damage triggers glioma stem cell differentiation through precise regulation of SOX2 stability by DNA-PK and WWP2, suggesting this pathway may be a possible therapeutic target of glioblastoma (Figure 5B).